UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
37 hedge funds and large institutions have $3.1M invested in Unity Biotechnology in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
39% less capital invested
Capital invested by funds: $5.09M → $3.1M (-$1.98M)
Holders
37
Holding in Top 10
2
Calls
$49K
Puts
–
Top Buyers
| 1 | +$34.5K | |
| 2 | +$24.4K | |
| 3 | +$20.7K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18.2K |
| 5 |
Squarepoint
New York
|
+$17.9K |
Top Sellers
| 1 | -$117K | |
| 2 | -$102K | |
| 3 | -$83.9K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$59.5K |
| 5 |
Renaissance Technologies
New York
|
-$16.4K |